Fette Tablet Press Produces High Volumes - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fette Tablet Press Produces High Volumes


Fette's FE75 Tablet Press, a double-sided rotary press, is designed for large batches and can be equipped with up to 115 punch stations to produce more than 1.6 million tablets per hour. The FE75’s four compression rollers feature a special control system for direct compression, enabling the machine to operate with two intermediate pressures.

The FE75 Tablet Press shares several technologies with the FE Series’ other two machines, the FE35 and FE55.  Common features include a patent-pending conical filling unit, highly accurate manually adjustable filling table, a revamped operating terminal, and the connection of process equipment through a standardized plug-and-play interface.  While the FE35 single-sided rotary press is optimized for quick changeovers and the FE55 offers maximum flexibility in diverse production scenarios, the FE75 has been specifically tailored to high-volume output for large batch production.

The FE75 has a footprint of only two square meters and is the only double-sided rotary press of its size that enables users to press single- and double-layer tablets as well as powder. Pneumatically controlled tablet scrapers guarantee a constant surface pressure and minimize product loss.  New conical filling units allow for the easier, safer processing of complex product mixtures, and tablet contamination is significantly hindered by a lubrication system that separates the lubrication of punch head and punch shaft in combination with a closed-cam track system. The FE75 chassis is designed with a two-part frame structure and a pneumatic suspension system for optimum vibration dampening.

The FE Series incorporates Fette Compacting’s TRI.EASY design concept of ease of use during production, changeover, and maintenance that is irrespective of an operator’s experience and qualifications. A new approach to turret changing, for example, uses a patent-pending process by which the turret is raised using a lifting mechanism. All steps involved in turret changeover have been automated or designed for tool-less execution. In addition, a new extraction unit features a tubeless design with fixed positioning to ensure correct installation.

Source: Fette

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here